Category: Medmonitor

August 24, 2023
Tornado Damages Pfizer Pharmaceutical Plant, Drug Shortages May Follow

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

READ MORE
July 25, 2023
FDA Publishes Guidance on Clinical Trials for Psychedelic Drugs

These guidelines advise researchers on study design and other considerations as they develop medications that contain psychedelics.

READ MORE
June 21, 2023
Brixadi Approved for Opioid Use Disorder

A new buprenorphine injection will be available for weekly or monthly dosages, administered by providers.

READ MORE
May 22, 2023
Drug Recalls for Pain Medications

Teva is recalling certain lots of fentanyl buccal tablets, while Family Dollar is recalling Advil that was not kept at proper temperature.

READ MORE
April 18, 2023
FDA Approves First Over-the-Counter Naloxone Nasal Spray

Patients will no longer need a prescription for this opioid overdose antidote.

READ MORE
March 21, 2023
FDA Approves Combogesic for Short Term Management of Mild to Moderate Pain

A new combination of acetaminophen and ibuprofen will soon hit the market.

READ MORE
January 23, 2023
HIV Medications: New Approval and News of Discontinuations

Sunlenca approved for treatment-resistant populations, but a number of other drugs will cease production, some of which are included in PEP guidelines.

READ MORE
December 21, 2022
FDA Approves Drug That Can Delay Onset of Type 1 Diabetes

Tzield (teplizumab-mzwv) injections can delay onset by several months or years.

READ MORE
November 17, 2022
Wave of Generic Approvals That Impact Workers’ Comp

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

READ MORE
October 18, 2022
FDA Advises Against NSAID Use in Pregnant Women at 20 Weeks and Later

The potential for low amniotic fluid can cause significant health issues.

READ MORE
1 2 3 7
lockenvelopephone-handsetmagnifiermenucross-circle